Stockscreener 앱 받기
2.48
93.75%
1.20
시간 외 거래:
2.48
전일 마감가:
$1.28
열려 있는:
$2.1
하루 거래량:
156.09M
Relative Volume:
42.55
시가총액:
$26.75M
수익:
$144.00K
순이익/손실:
$-14.50M
주가수익비율:
-1.7102
EPS:
-1.4501
순현금흐름:
$-14.95M
1주 성능:
+58.97%
1개월 성능:
+43.35%
6개월 성능:
-50.70%
1년 성능:
-44.02%
1일 변동 폭
$2.02
$2.83
1주일 범위
$1.22
$2.83
52주 변동 폭
$1.22
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
명칭
Serina Therapeutics Inc
전화
(256) 327-9630
주소
601 GENOME WAY, HUNTSVILLE
Compare SER vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
2.48 | 13.81M | 144.00K | -14.50M | -14.95M | -1.4501 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-14 | 개시 | H.C. Wainwright | Buy |
Serina Therapeutics Inc 주식(SER)의 최신 뉴스
Serina Therapeutics (SER) Stock Soars 39% After Announcing $63M Funding and Leadership Boost - parameter.io
Serina Therapeutics (SER) Stock Jumps 39% Following $63M Financing Deal and Leadership Announcement - Blockonomi
Serina Therapeutics (SER) Stock Soars 39% After $30M Funding Deal and Leadership Boost - MoneyCheck
SER Stock Surges Amid Strategic Acquisitions and Partnerships - StocksToTrade
Serina Therapeutics (SER) Stock Climbs 39% on Private Placement and Greg Bailey Appointment - CoinCentral
Serina Therapeutics’ Stock Hits All-Time Low Amid Financial Challenges - timothysykes.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN
Serina Therapeutics (SER) Stock Surges Over 39% After Hours— Here's Why - Benzinga
Serina Therapeutics, Inc. Appoints Greg Bailey as Co-Chairman of the Board of Directors - marketscreener.com
Serina Therapeutics Raises $30 Million in Private Placement - marketscreener.com
Parkinson's drug trial gets up to $30M as Serina adds board co-chair - Stock Titan
Macro Review: What is the dividend yield of Serina Therapeutics IncTrade Entry Report & Smart Investment Allocation Insights - baoquankhu1.vn
Serina Therapeutics, Inc. announced that it expects to receive $30 million in funding - marketscreener.com
Aug Swings: Is Serina Therapeutics Inc benefiting from innovation trends2026 Investor Takeaways & High Yield Stock Recommendations - baoquankhu1.vn
Aug Action: Does Serina Therapeutics Inc have declining or rising EPS2026 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
How Serina Therapeutics Inc. stock reacts to inflationary pressuresJuly 2025 Technicals & Low Risk Growth Stock Ideas - Naître et grandir
How Serina Therapeutics Inc. stock benefits from global expansionJuly 2025 Chart Watch & Real-Time Buy Signal Alerts - Naître et grandir
Serina Therapeutics Advances SER-252 Parkinson’s Trial, Marking a Key Early Milestone for Investors - TipRanks
Entry Recap: Is Zillow Group Inc showing insider buying2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Serina Therapeutics Announces Dosing of First Patient in - GlobeNewswire
New drug SER-252 enters Phase 1b trial for advanced Parkinson's - Stock Titan
SER SEC FilingsSerina Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Serina Therapeutics2026 Funding Rounds & List of Investors - Tracxn
Serina Begins Phase 1b Registrational Trial Of SER-252 In Advanced Parkinson's - Nasdaq
First patient enrolled in Serina’s Parkinson’s disease trial - Investing.com
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease - The Manila Times
New Parkinson's trial enrolls first patient as Serina targets advanced disease - Stock Titan
SER PE Ratio & Valuation, Is SER Overvalued - Intellectia AI
Director Simba Gill granted 92,000 Serina Therapeutics (SER) stock options - Stock Titan
What are Serina Therapeutics Inc.’s recent SEC filings showingWeekly Loss Report & Fast Momentum Entry Tips - mfd.ru
Momentum Shift: Is CERo Therapeutics Holdings Inc likely to announce a buybackMarket Movers & High Accuracy Swing Trade Signals - baoquankhu1.vn
Aug Drivers: Whats next for Marchex Inc stockShort Setup & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Is Serina Therapeutics Inc. benefiting from interest rate changesTrade Performance Summary & Technical Entry and Exit Tips - mfd.ru
Will Serina Therapeutics Inc. stock outperform international peersJuly 2025 Big Picture & Expert Approved Momentum Trade Ideas - mfd.ru
Published on: 2026-02-05 05:58:49 - mfd.ru
Serina Therapeutics CSO sells $19,680 in shares By Investing.com - Investing.com South Africa
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event - The Globe and Mail
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event - Finviz
Bull Bear: Is Serina Therapeutics Inc a stock for growth or value investorsTrade Entry Summary & Smart Swing Trading Techniques - baoquankhu1.vn
Stock Recap: Is Serina Therapeutics Inc a stock for growth or value investorsEarnings Performance Report & High Conviction Investment Ideas - baoquankhu1.vn
Serina Therapeutics Insider Sells $23K in Stock - National Today
Why did SER stock surge over 70% in pre-market today? - MSN
Bull Run: What are Serina Therapeutics Incs recent SEC filings showingMarket Growth Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
Serina Therapeutics CSO sells $23,185 in shares By Investing.com - Investing.com Canada
Serina Therapeutics CSO sells $23,185 in shares - Investing.com
Serina Therapeutics Stock Soars Amid Strategic Partnership Announcements - StocksToTrade
Serina Therapeutics Announces FDA Clearance of IND - GlobeNewswire
Serina Jumps On FDA's IND Clearance For SER-252 In Advanced Parkinson's Disease After Clinical Hold - Nasdaq
What Sparked Serina Therapeutics (SER) 35% After-Hours Surge? - Finviz
Serina Therapeutics stock soars after FDA clears IND for Parkinson’s drug By Investing.com - Investing.com South Africa
Serina Therapeutics Inc (SER) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):